Outlook Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.21

+0.00 (+1.65%)

As of Apr 1, 3:55 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +16,525.2% upside

Low Target $27.07

Average Target $34.78

High Target $51.13

Current Price $0.21

Current
$0.21

Target
$34.78

$27.07 $34.78 avg $51.13

Scenario Analysis

Bear Case

$27.07

12,839.8%

Low target

Base Case

$34.78

+16,525.2%

Avg target

Bull Case

$51.13

+24,340.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.39

-93.8% from high

52-Week Low

$0.16

+29.9% from low

Target vs 52W High

$34.78

+926.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%